NEW YORK, May 26, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:
Epidemiology: Cervical Cancer
http://www.reportlinker.com/p0511974/Epidemiology-Cervical-Cancer.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology
Introduction
Historical, and consequently future, incidence trends of cervical cancer are primarily related to access to and utilization of cervical cytology screening programs. Cervical cancer is also the seventh most commonly diagnosed cancer among women in the developed world. Datamonitor expects the number of cervical cancer incidence cases to decrease by 4% between 2010 and 2020 in the seven major markets.
Features and benefits
* Gain insight to market potential, including a robust 10-year epidemiology forecast of cervical cancer incident cases.
* Understand the key epidemiologic risk factors associated with cervical cancer.
Highlights
During 2010, Datamonitor estimates that 35,898 women will develop cervical cancer in the seven major markets. The largest number of cases will be in the US (13,170). Germany and Japan will see the next largest burdens of incident cases (5,700 and 5,420, respectively); with the UK, Italy, France, and Spain having the least (approx. 3,200 to 2,000).
Between 2010 and 2020, total cervical cancer incident cases in the seven major markets are expected to decrease slightly by 4%. This weak decreasing trend is due to forecasted decreases in incidence rates alongside forecasted increases in the most susceptible populations during the 2010 to 2020 time period.
Your Key questions answered
* What are the most robust sources for cervical cancer incidence data?
* How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
* What are the major risk factors for cervical cancer that drive the trend in incident cases and how are they changing?
Executive Summary
Disease burden overview
Forecast results (2010–20)
OVERVIEW
Catalyst
Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Definition of cervical cancer
GLOBAL VARIATION AND HISTORICAL TRENDS
Incidence varies across the seven major markets
RISK FACTORS
Overview
Human papillomavirus exposure risk factors
Number of sexual partners
Sexual history of partner(s)
Age at first sexual experience
Risk factors for progression to cervical cancer following human papillomavirus infection
Smoking
Co-infection with other sexually transmitted infections, including HIV
Oral contraceptive use
Parity
Infrastructural and social risk factors: screening and care, socioeconomic status, race, and geography
Screening frequency
Race (US)
Socioeconomic status and geography (US)
EPIDEMIOLOGIC FORECASTING OF CERVICAL CANCER
Cancer registries: age- and country-specific incidence rates
Population denominators
Description of methods
Categorization and stratification
Incidence forecasting
US
Japan
France
Germany
Italy
Spain
UK
EPIDEMIOLOGIC RESULTS
Estimated incident cases of cervical cancer and future trends
Segmentation of incident cases: 2010
DISCUSSION
US
Japan
Five major EU markets
Conclusions
BIBLIOGRAPHY
Journal papers
Websites
APPENDIX A
Module methodology
To order this report:
Pathology Industry: Epidemiology: Cervical Cancer
Pathology Business News
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas BombourgReportlinkerEmail: [email protected]US: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
Advertisement
Epidemiology: Cervical Cancer
http://www.reportlinker.com/p0511974/Epidemiology-Cervical-Cancer.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology
Advertisement
Introduction
Historical, and consequently future, incidence trends of cervical cancer are primarily related to access to and utilization of cervical cytology screening programs. Cervical cancer is also the seventh most commonly diagnosed cancer among women in the developed world. Datamonitor expects the number of cervical cancer incidence cases to decrease by 4% between 2010 and 2020 in the seven major markets.
Features and benefits
* Gain insight to market potential, including a robust 10-year epidemiology forecast of cervical cancer incident cases.
* Understand the key epidemiologic risk factors associated with cervical cancer.
Highlights
During 2010, Datamonitor estimates that 35,898 women will develop cervical cancer in the seven major markets. The largest number of cases will be in the US (13,170). Germany and Japan will see the next largest burdens of incident cases (5,700 and 5,420, respectively); with the UK, Italy, France, and Spain having the least (approx. 3,200 to 2,000).
Between 2010 and 2020, total cervical cancer incident cases in the seven major markets are expected to decrease slightly by 4%. This weak decreasing trend is due to forecasted decreases in incidence rates alongside forecasted increases in the most susceptible populations during the 2010 to 2020 time period.
Your Key questions answered
* What are the most robust sources for cervical cancer incidence data?
* How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
* What are the major risk factors for cervical cancer that drive the trend in incident cases and how are they changing?
Executive Summary
Disease burden overview
Forecast results (2010–20)
OVERVIEW
Catalyst
Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Definition of cervical cancer
GLOBAL VARIATION AND HISTORICAL TRENDS
Incidence varies across the seven major markets
RISK FACTORS
Overview
Human papillomavirus exposure risk factors
Number of sexual partners
Sexual history of partner(s)
Age at first sexual experience
Risk factors for progression to cervical cancer following human papillomavirus infection
Smoking
Co-infection with other sexually transmitted infections, including HIV
Oral contraceptive use
Parity
Infrastructural and social risk factors: screening and care, socioeconomic status, race, and geography
Screening frequency
Race (US)
Socioeconomic status and geography (US)
EPIDEMIOLOGIC FORECASTING OF CERVICAL CANCER
Cancer registries: age- and country-specific incidence rates
Population denominators
Description of methods
Categorization and stratification
Incidence forecasting
US
Japan
France
Germany
Italy
Spain
UK
EPIDEMIOLOGIC RESULTS
Estimated incident cases of cervical cancer and future trends
Segmentation of incident cases: 2010
DISCUSSION
US
Japan
Five major EU markets
Conclusions
BIBLIOGRAPHY
Journal papers
Websites
APPENDIX A
Module methodology
To order this report:
Pathology Industry: Epidemiology: Cervical Cancer
Pathology Business News
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas BombourgReportlinkerEmail: [email protected]US: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
